Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine for Ultrasound-guided Intermediate Cervical Plexus Block in Patients Undergoing Thyroidectomy

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

Background: Many thyroidectomy patients suffer from postoperative pain that could delay early hospital discharge and place a significant burden on both the patient and the healthcare team. Bilateral intermediate cervical plexus block (ICPB) provides good analgesia for neck surgery, including thyroidectomy. However, the duration of a single-shot nerve block is usually short. Therefore, adjuvants are used in peripheral nerve blocks.

Objectives: To compare the safety and efficacy of dexmedetomidine versus dexamethasone as adjuvants to bupivacaine in ultrasound-guided intermediate cervical plexus block in patients undergoing total thyroidectomy under general anesthesia. Patients and

Methods: This is a randomized, double-blind, phase four, prospective clinical trial; carried out on 60 patients, who were candidates for total thyroidectomy under general anesthesia at our hospital. Patients were randomly allocated into two equal groups; group A, received bilateral ICPB with isobaric bupivacaine plus dexmedetomidine, and group B, received bilateral ICPB with isobaric bupivacaine plus dexamethasone.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 60
Healthy Volunteers: f
View:

• American Society of Anesthesiologists (ASA) physical status ≤ II

• Age from 21 to 60 years

• Body Mass Index (BMI) ≤ 35 kg/m2

Locations
Other Locations
Egypt
Damanhour Teaching Hospital
RECRUITING
Damanhūr
Contact Information
Primary
Ahmed M Shaat, MD
ahmedshaat99@gmail.com
00201223482709
Time Frame
Start Date: 2024-08-01
Estimated Completion Date: 2025-12-15
Participants
Target number of participants: 60
Treatments
Active_comparator: Group A (n=30)
Dexmedetomidine group
Active_comparator: Group B (n=30)
Dexamethasone group
Related Therapeutic Areas
Sponsors
Leads: Damanhour Teaching Hospital

This content was sourced from clinicaltrials.gov